Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMYMP) Non Operating Income (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Non Operating Income for 17 consecutive years, with $51.0 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 116.72% to $51.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$674.0 million through Dec 2025, up 24.52% year-over-year, with the annual reading at -$674.0 million for FY2025, 24.52% up from the prior year.
  • Non Operating Income for Q4 2025 was $51.0 million at Bristol Myers Squibb, down from $108.0 million in the prior quarter.
  • The five-year high for Non Operating Income was $702.0 million in Q1 2021, with the low at -$649.0 million in Q1 2022.
  • Average Non Operating Income over 5 years is -$13.2 million, with a median of $26.5 million recorded in 2021.
  • The sharpest move saw Non Operating Income crashed 14300.0% in 2022, then soared 163.64% in 2023.
  • Over 5 years, Non Operating Income stood at -$393.0 million in 2021, then skyrocketed by 155.22% to $217.0 million in 2022, then surged by 70.97% to $371.0 million in 2023, then tumbled by 182.21% to -$305.0 million in 2024, then surged by 116.72% to $51.0 million in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $51.0 million, $108.0 million, and -$494.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.